- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Oxidative Medicine and Cellular Longevity
Volume 2013 (2013), Article ID 136570, 10 pages
Study of Possible Mechanisms Involved in the Inhibitory Effects of Coumarin Derivatives on Neutrophil Activity
1Institute of Experimental Pharmacology and Toxicology Slovak Academy of Sciences, Dúbravská cesta 9, 841 04 Bratislava, Slovakia
2Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v. v. i., Flemingovo náměsti 2, 161 10 Prague, Czech Republic
3Institute of Chemical Technology Prague, Technická 5, 166 28 Prague, Czech Republic
Received 22 July 2013; Revised 17 October 2013; Accepted 17 October 2013
Academic Editor: David Vauzour
Copyright © 2013 Katarína Drábiková et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
To specify the site of action of the synthetic coumarin derivatives 7-hydroxy-3-(4′-hydroxyphenyl) coumarin (HHC) and 7-hydroxy-3-(4′-hydroxyphenyl) dihydrocoumarin (HHDC), we evaluated their effects on extra- and intracellular reactive oxygen species (ROS) formation in phorbol-myristate-13-acetate (PMA) stimulated human neutrophils. We studied also the effects of HHC and HHDC on possible molecular mechanisms which participate in the activation of NADPH oxidase, that is, on PKC activity, on phosphorylation of some PKC isoforms (α, βII, and δ), and on phosphorylation of the NADPH oxidase subunit p40phox. Without affecting cytotoxicity, both coumarines tested were effective inhibitors/scavengers of ROS produced by neutrophils on extracellular level. HHC markedly diminished oxidant production and also, intracellularly, decreased PKC activity and partly phosphorylation of PKCα, βII. On the other hand, we did not observe any effect of coumarin derivatives on phosphorylation of PKCδ and on phosphorylation of the NADPH oxidase subunit p40phox, which were suggested to be involved in the PMA-dependent intracellular activation process. In agreement with our previous findings, we assume that the different molecular structures of HHC and HHDC with their different physicochemical and free radical scavenging characteristics are responsible for their diverse effects on the parameters tested.
Neutrophils are key cells of the first line of defense, but they are also considered potent inflammatory cells causing tissue damage. Thus the ability of compounds which prevent extensive and potentially dangerous activation of neutrophils has been proposed as an important injury-limiting way. Coumarins belong to the group of plant-derived polyphenolic compounds possessing broad biochemical and pharmacological effects, like anti-HIV, anti-inflammatory, antioxidant, antibacterial, anticoagulant, and anticancer activities [1–4]. Over the last years, natural as well as synthetic coumarins were extensively studied and many of them are considered attractive candidates in therapeutic development.
Production of reactive oxygen species (ROS) in neutrophils and other phagocytic cells is linked to the activation of NADPH oxidase, a multiprotein enzyme complex, which plays an essential role in innate immunity. Yet excessive ROS generation by phagocytes is involved in tissue injury associated with a number of chronic inflammatory diseases [5–7]. In resting cells, NADPH oxidase is inactive and its components are distributed between the cytosol and membranes. When cells are activated, the cytosolic components (p40phox, p47phox, p67phox, and Rac2) migrate to the membranes, where they associate with the membrane-bound component (flavocytochrome b558) to assemble the catalytically active NADPH oxidase, resulting in the delivery of ROS into the extracellular environment or inside into the phagocytic vesicle [8–10]. NADPH oxidase is also activated within specific intracellular compartments, leading to an intracellular ROS production which may have a direct role in signal transduction. It was reported that the cytosolic component of the NADPH oxidase, p40phox, associates with cytochrome b, especially in intracellular membranes [10–13]. Localisation of neutrophil ROS production and its possible regulation thus play an important role in the development of effective treatments to control the damage associated with chronic inflammation [8, 14].
Protein kinase C (PKC) has been shown to activate NADPH oxidase in several types of cells, such as phagocytes, cardiomyocytes, aortic endothelial cells, vascular smooth muscle cells, and renal mesangial cells [15, 16]. Various PKC isoforms have been shown to stimulate superoxide production, including α, β, δ, ε, and ζ [17, 18]. Neutrophils are strongly activated by PKC activating phorbol esters, which together with the expression of several PKC isoforms in neutrophils suggest a role for PKC in neutrophil functions . Human neutrophils contain multiple isotypes of PKC, including Ca2+/DG-dependent isotypes-α; alternatively spliced βI and βII; Ca2+-independent/DG-dependent isotype δ; and phosphatidylserine-dependent Ca2+/DG-independent ξ [19, 20]. In cell-free systems, PKCα, β, and δ are implicated as regulators of NADPH oxidase and superoxide generation . Moreover, PKCδ has been suggested to be responsible for intracellular ROS generation in PMA activated neutrophils .
Previously, we compared the effect of 7-hydroxy-3-(4′-hydroxyphenyl) coumarin (HHC) and 7-hydroxy-3-(4′-hydroxyphenyl) dihydrocoumarin (HHDC) on stimulated phagocyte functions with their physicochemical characteristics and free radical scavenging activities in chemical assays .
To specify the site of action of the synthetic coumarin derivatives HHC and HHDC (Figure 1), we evaluated their effects on extra- and intracellular ROS formation in PMA stimulated human neutrophils. We also studied the effects of HHC and HHDC on possible molecular mechanisms which participate in the activation of NADPH oxidase: on PKC activity, phosphorylation of some PKC isoforms (α, βII, and δ), and on phosphorylation of the subunit p40phox.
2. Material and Method
Phorbol-myristate-13-acetate (PMA), luminol (5-amino-2,3-dihydro-1,4-phthalazinedione), isoluminol (6-amino-2,3-dihydro-1,4-phthalazinedione), superoxide dismutase, dextran (average MW 464.000), and protease inhibitor cocktail: 104 mmol/L AEBSF [4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride], 0.085 mmol/L aprotinin, 1.53 mmol/L bestatin hydrochloride, 1.40 mmol/L E-64 [N-(trans-epoxysuccinyl)-L-leucine 4-guanidinobutylamide], 1.90 mmol/L leupeptin hemisulfate salt, and 4.22 mmol/L pepstatin in DMSO, were purchased from Sigma-Aldrich Chemie (Deisenhofen, Germany), horse radish peroxidase (HRP) and catalase from Merck (Darmstadt, Germany), and Lymphoprep (density 1.077 g/mL) from Nycomed Pharma AS (Oslo, Norway).
HHC and HHDC were kindly provided by Dr. Juraj Harmatha from the Institute of Organic Chemistry and Biochemistry, AV ČR, Prague, Czech Republic, and Professor Jan Šmidrkal from the Institute of Chemical Technology, Department of Dairy and Fat Technology, AV ČR, Prague, Czech Republic.
HHC (1.27 mg) was dissolved in a mixture of 20 μL 1 NaOH and 980 μL Tyrode solution (Tyrode solution consisted of 136.9 mmol/L NaCl, 2.7 mmol/L KCl, 11.9 mmol/L NaHCO3, 0.4 mmol/L NaH2PO4 · 2H2O, 1 mmol/L MgCl2 · 6H2O, and 5.6 mmol/L glucose, pH 7.4). The stock solution (5 mmol/L) was further diluted with Tyrode solution to give HHC samples, concentrations 0.01–100 μmol/L. The corresponding final concentrations of NaOH were 0.4–400 μmol/L; at these concentrations, the solvent agent alone did not reduce the activity and viability of neutrophils.
All other chemicals of analytical grade were from available commercial sources.
This work was approved by the Local Ethic Committee, Institute of Experimental Pharmacology and Toxicology SAS.
2.1. Blood Collection and Isolation of Human Neutrophils
Fresh blood was taken at the blood bank from healthy volunteers (men, aged 20 to 50 years) by antecubital venipuncture and was immediately mixed with 3.8% v/w trisodium citrate, in the ratio of 9 mL of blood to 1 mL of citrate, in polypropylene centrifugation tubes. Erythrocytes were allowed to sediment in 3% dextran solution (1 ×g, 25 min, 22°C) and neutrophils were separated by gradient centrifugation on Lymphoprep (500 ×g, 30 min, 22°C). After hypotonic lysis of contaminating erythrocytes, neutrophils were washed and resuspended in calcium- and magnesium-free phosphate buffer saline in mmol/L: 137 NaCl, 2.7 KCl, 8.1 Na2HPO4, 1.5 KH2PO4, and pH 7.4, at final concentration of 1 × 107 cells/mL. The obtained cell suspension contained more than 96% viable cells, as evaluated by trypan blue exclusion [24, 25]. Prior to neutrophil activation studies, the cells were resuspended in phosphate buffer saline (PBS) in mmol/L: 137 NaCl, 2.7 KCl, 8.1 Na2HPO4, 1.5 KH2PO4, 1.8 CaCl2, 0.5 MgCl2 · 6H2O, and pH 7.4.
2.2. Chemiluminescence Assay of Isolated Neutrophils
The effect of HHC or HHDC (0.01, 0.1, 1, 10, and 100 μmol/L) on extra- and intracellular ROS production was measured in unstimulated and PMA (0.05 μmol/L) stimulated neutrophils (5 × 105/sample) by isoluminol-/luminol-enhanced chemiluminescence (CL). Extracellular CL was determined in the system containing isoluminol (5 μmol/L) and HRP (8 U/mL). Intracellular CL was measured with luminol (5 μmol/L) in the presence of the extracellular scavengers superoxide dismutase (100 U/mL) and catalase (2 000 U/mL). CL was evaluated in a microplate luminometer Immunotech LM-01T (Czech Republic) at 37°C. Data were based on integral values of CL over 1800 s, (RLU × s; RLU: relative light units) [26, 27].
2.3. Chemiluminescence Assay in Cell-Free System
In the cell-free system, luminol, horseradish peroxidase, and hydrogen peroxide were used for chemiluminescence generation . The 200 μL samples consisted of 50 μL aliquots: HRP (2 U/mL), luminol (10 μmol/L), HHC, or HHDC solutions in the concentrations of 1, 10, or 100 μmnol/L. The reaction was initiated by adding hydrogen peroxide at the final concentration of 100 μmol/L. The chemiluminescence responses were measured for 10 minutes at 37°C in a microplate luminometer Immunotech LM-01T (Czech Republic).
2.4. PKC Activity Assay
PKC activity in the cytosol was detected by the modified method of Varga et al. . Isolated human neutrophils (/mL) were incubated 30 min with HHC (1, 10, and 100 μmol/L) or HHDC (1, 10, and 100 μmol/L) at 37°C. Neutrophils were then stimulated with PMA (0.15 μmol/L, final concentration) at 37°C for 3 min. The reaction was stopped by addition of 10 vol of ice-cold PBS. After centrifugation (500 ×g, 4°C, 10 min) the cells were resuspended in sample buffer (20 mmol/L TRIS-HCl, 5 mmol/L EDTA, 1% Triton, 10% glycerol, and protease inhibitor cocktail), sonicated on ice, and centrifuged (14 000 ×g, 5 min, 4°C). The cytosolic fractions were transferred to a prechilled 1.5 mL microcentrifuge tube and stored at –70°C. Protein content of cytosol fraction was measured using Bradford Dye Reagent Detection Kit (Bio-Rad, USA). PKC activity was measured with a Nonradioactive Protein Kinase Assay kit (Assay Designs, Ann Arbor, MI, USA), which is based on a solid-phase enzyme-linked immunoabsorbent assay (ELISA), utilising a specific synthetic peptide as substrate for PKC and a polyclonal antibody recognizing the phosphorylated form of the substrate. The assay is developed with tetramethylbenzidine substrate and a colour develops in proportion to PKC phosphotransferase activity. The colour development was stopped with acid stop solution and the intensity of the colour was measured in a microplate reader at 450 nm. The data were expressed as relative kinase activity per 1 mg of protein.
2.5. Western-Blot Analysis
The suspension of isolated neutrophils (100 μL) containing cells was preincubated at 37°C for 60 seconds with different concentrations of HHC or HHDC (10, 100 μmol/L) prior to addition of PMA (0.15 μmol/L). Incubation with PMA (5 min) was stopped by using a solubilisation buffer (20 mmol/L Tris-HCl, 5 mmol/L EDTA, 1% Triton, 10% glycerol, 10 mmol/L NaF, 1 mmol/L sodium orthovanadate, 208 μmol/L AEBF, 0.17 μmol/L aprotinin, 8 μmol/L bestatin, 2.8 μmol/L E-64, 4 μmol/L leupeptin, and pH 7.4). The suspension was sonicated at 4°C for 20 minutes and centrifuged at 14 000 ×g at 4°C for 5 min to remove unbroken cells. The supernatant was taken for measuring total protein by using Bradford Dye Reagent Detection Kit from Bio-Rad and for blotting assay. The supernatant for blotting assay was boiled for 5 min with sample buffer (50 mmol/L Tris-HCl, 2% SDS, 7.5% glycerol, 2.5% mercaptoethanol, 0.01% bromophenol blue, and pH 6.8) and samples were loaded on 9.8% SDS polyacrylamide gels. Proteins (20 μg per lane) were separated by electrophoresis and transferred to Immobilon-P Transfer Membrane (Millipore Corp., USA). From the two strips taken, one was detected for PKCα, βII (area between 60 and 100 kD) and the second for detection of β-actin (30–60 kD), which represented the internal control. Membrane strips were blocked for 60 min with 1% bovine serum albumin in Tris buffered saline (TBS: 20 mmol/L Tris-HCl, 154 mmol/L NaCl, 0.05% Tween-20, and pH 7.5). This was then followed by 60 min incubation in the presence of the primary antibodies: anti-phospho-PKC-α, βII (Thr638/641) (1 : 5 000) or β-actin (rabbit anti-human, 1 : 4 000) (Cell Signaling Technology, Danvers, MA, USA). The membranes were subsequently washed six times with TBS and incubated 60 min with the secondary antibody conjugated to horseradish peroxidase (anti-rabbit from donkey, 1 : 5 000, GE Healthcare Life Sciences, Little Chalfont, UK), and the activity of horseradish peroxidase of the bands corresponding to individual PKC isoforms was visualised using Enhanced Chemiluminescence Western Blotting Detection Reagents (GE Healthcare Life Sciences, Little Chalfont, UK).
NADPH oxidase subunit p40phox and PKC isoenzyme δ were detected in the same blots after their washing and incubation with 10x diluted stripping buffer (Reblot Plus Mild Solution, Millipore, Temecula, CA, USA) for 15 min and washed overnight in diluent buffer (1% bovine serum albumin in Tris buffered saline). This was followed by 60 min incubation in the presence of primary antibodies: anti-phospho-p40phox (T154) (1 : 5 000) or PKCδ (Thr505) (1 : 1 000) (Cell Signaling Technology, Danvers, MA, USA). The membranes were subsequently washed six times with TBS and incubated 60 min with the secondary antibody conjugated to horseradish peroxidase (anti-rabbit from donkey, 1 : 5 000, GE Healthcare Life Sciences, Little Chalfont, UK), and the activity of horseradish peroxidase of the bands corresponding to the individual NADPH oxidase subunit or to PKC isoform was visualised using Enhanced Chemiluminescence Western Blotting Detection Reagents (GE Healthcare Life Sciences, Little Chalfont, UK). Autoradiogram bands were quantified using the Image J programme. The optical density of each PKC or NADPH oxidase band was corrected by the optical density of the corresponding β-actin band [24, 27].
2.6. Measurement of Cytotoxicity
The cytotoxic effect of HHC and HHDC was evaluated by means of ATP liberation by the luciferin-luciferase chemiluminescence. The neutrophil suspension (30 μL; 30 000 cells/sample) and 20 μL of Tyrode’s solution were incubated with 50 μL of HHC or HHDC (1–100 μmol/L) for 15 min at 37°C. Ten microliters of a mixture of luciferin (1.6 μg/sample) and luciferase (45 000 U/sample) was added, and the chemiluminescence was recorded for 60 s. In each experiment, the chemiluminescence of ATP standards (1–500 nmol/L) was measured and the concentrations of ATP in samples were calculated from the calibration curve. The total ATP content was assessed immediately after sonication of neutrophils for 10 s [24, 27].
2.7. Statistical Analyses
All values are given as means of 4–8 experiments ± SEM. Statistical significance of differences between means was established by Student’s -test and values below 0.05 were considered statistically significant.
3.1. Effects of HHC and HHDC on ATP Liberation
To determine cytotoxicity of HHC and HHDC, we tested their effect on ATP liberation (Table 1). In the concentrations of 1, 10, and 100 μmol/L, these compounds did not increase spontaneous ATP liberation ( nmol/L ATP), representing 7.6% of the total ATP content ( nmol/L ATP), as determined immediately after complete neutrophil destruction. The results indicate that treatment with increasing concentrations of HHC and HHDC did not cause neutrophil damage.
3.2. Effects of HHC and HHDC on Extra- and Intracellular Chemiluminescence of Neutrophils
For activation of isolated human neutrophils, the soluble stimulus PMA was used, which bypasses receptors and activates NADPH oxidase via redistribution of PKC and phosphorylation of several proteins. As mentioned above, PMA is useful in investigating signal transduction pathways leading to NADPH-oxidase activation in plasma (extracellular) and granule membranes (intracellular) [10, 11]. Figure 2 demonstrates kinetics of extra- and intracellular ROS generation in isolated human neutrophils after PMA stimulation. The extracellular ROS generation was much more intensive and reached the maximum sooner than did the intracellular ROS generation. The ratio between extra- and intracellular ROS generation was approximately 10 : 1 (12 696 RLU : 1 295 RLU).
Figure 3 shows that both compounds, HHC and HHDC, in the concentration scale of 0.01–100 μmol/L, decreased significantly extracellular ROS production, as measured by chemiluminescence. The concentrations of HHC and HHDC producing 50% inhibition (IC50) of control extracellular chemiluminescence were 1.04 ± 0.20 μmol/L and 1.01 ± 0.13 μmol/L, respectively (Table 2).
While HHC in the concentration scale of 0.01–100 μmol/L decreased significantly intracellular ROS production (IC50: 5.24 ± 0.57 μmol/L), HHDC was slightly effective only in the highest concentration tested (Figure 4 and Table 2).
3.3. Effects of HHC and HHDC on Cell-Free Chemiluminescence System
Further we tested the participation of direct antioxidant activity of HHC and HHDC in a cell-free CL system consisting of luminol, horseradish peroxidase, and hydrogen peroxide. Our results showed an effective inhibition of chemiluminescence generated by cell-free system with HHC (IC50: 0.59 ± 0.01) and HHDC (IC50: 2.47 ± 0.04) (Table 2).
3.4. Effects of HHC and HHDC on PKC Activity and on the Phosphorylation of the PKC Isoforms (PKCα, βII, and δ)
Stimulation of neutrophils with phorbol esters activates the PKC isoforms α, βII, and δ, which are involved in the oxidative burst as key activators of NADPH oxidase. First we analysed whether modulation of PKC activity by HHC or HHDC might mediate their inhibitory effect on PMA stimulated ROS production. HHC in the concentrations of 1, 10, and 100 μmol/L significantly decreased PKC activity to 87.7 ± 4.2%, 74.8 ± 6.3%, and 46.3 ± 1.8%, respectively. On the other hand, HHDC did not significantly influence PKC activity (Figure 5). Since the PKC activity assay determined all PKC isoforms (α, β, γ, δ, ε, μ, ζ, and θ), we further specified the effect of HHC and HHDC on phosphorylation of PKCα, βII, and δ.
After PMA stimulation, we observed increased phosphorylation of PKCα, βII, and δ in comparison with unstimulated human neutrophils. Treatment with HHC or HHDC in the concentrations of 10 and 100 μmol/L resulted in decrease in the level of PKCα, βII as compared to those of control but did not affect phosphorylation of PKCδ (Figures 6 and 7).
3.5. Effects of HHC and HHDC on the Phosphorylation of the NADPH Oxidase Component p40phox
Recently, the selective role for p40phox in intracellular ROS production was reported [10, 13]. We studied whether the observed inhibition of intracellular ROS production, particularly by HHC, might be connected with its effect on phosphorylation of p40phox subunit in PMA stimulated human neutrophils. As shown in Figure 8, PMA increased phosphorylation of p40phox subunit, yet HHC and HHDC failed to influence it.
Regulation of neutrophil activity is one of the important factors in achieving host defense and avoiding tissue-damaging inflammation. Recently, great attention has been devoted to polyphenols of natural origin as well as to their synthetic derivatives. Many of them were found to possess effects which could be used in prevention and support therapy of chronic inflammatory diseases [30–35]. Previously, we have suggested that different effects of phenylcoumarin derivatives HHC and HHDC on phagocyte functions may be due to their diverse free radical scavenging properties and lipophilicity features. Further, we indicated that the ability of HHC and HHDC to reduce oxidant production in neutrophils might be connected with inhibition of NADPH oxidase activity, via decrease of PKC activation . In the present study we specified the site of HHC and HHDC action on ROS generation and considered some possible molecular mechanisms linking regulation of oxidant production.
Our results showed that neutrophils activated by PMA responded by an oxidant production composed of both extra- and intracellular component of chemiluminescence. We found the extracellular ROS production to be predominant, as also demonstrated by Björnsdottir et al.  and Dahlgren and Karlsson ; however, in comparison with their results we observed a higher ratio between oxidants produced extra- and intracellularly, in favour of the former. HHC and HHDC were potent inhibitors of extracellular ROS production in human neutrophils stimulated with PMA. While HHDC reduced intracellular ROS generation only in the highest concentration tested, HHC possessed significant inhibitory effect in a concentration-dependent manner. The inhibition of both extra- and intracellular oxidant production indicated a possible interference of HHC and HHDC with ROS (scavenging activity) as well as with signalling events resulting in ROS production.
The effective inhibition of cell-free system chemiluminescence by both compounds tested (Table 2) showed that free radical scavenging properties of HHC and HHDC play an important role in the reduction of both extra- and intracellular oxidant production. The results obtained in cell-free system also suggest they interfere with peroxidase, since luminol reaction is highly dependent on the participation of myeloperoxidase. The possibility of this interaction with peroxidase is supported by findings of Kabeya et al.  and Andrade et al.  who demonstrated the inhibitory effect of 3-phenylcoumarin hydroxylated derivatives on horseradish peroxidase catalytic activity. The inhibitory effect of stilbene derivatives on myeloperoxidase release was described also by Pečivová et al. .
The relationships between antioxidant activities and chemical structures of coumarin derivatives are important factors which may influence the oxidant production in vitro and in vivo [1, 23, 38, 40–42]. Both coumarines tested, HHC and HHDC, have a similar structure: a hydroxyl group at C7 position at ring A and a hydroxyl group at C4′ position at ring B. While HHC has an unsaturated bond between C3 and C4 at ring C, HHDC fails to possess it (Figure 1). Our results indicate that the inhibitory effect of HHC and HHDC on PMA stimulated extracellular ROS generation in neutrophils is probably not dependent on the presence of a double bond between C3 and C4 at ring C. On the other hand, the more pronounced inhibition of intracellular ROS production by HHC indicates the requirement of an unsaturated 3-, 4-binding site at ring C for this inhibitory effect.
Polyphenols were reported to affect cell functions by modifying plasma membrane structure and physical characteristics, such as fluidity and electrical properties. These effects can be observed both when polyphenols are adsorbed on the membrane and when they are inserted into the bilayer . The low effect of HHDC on intracellular ROS generation might be explained by the lower values of the partition coefficient of HHDC compared to that of HHC and thus the more efficient penetration of HHC into the membrane than that of the less lipophilic HHDC, as shown by our earlier published findings .
In biological systems, ROS are generated by a number of enzymatic systems, and modifications of plasma membrane structure can result in functional changes, including the activity of membrane-associated enzymes and the modulation of signal transduction [7, 43].
Inhibition of PKC or downregulation of its intracellular expression and activity has been proposed as an important mechanism of the antioxidant effect of polyphenols [7, 27, 35, 44, 45]. We found that HHC, unlike HHDC, effectively decreased intracellular oxidant production involved in the regulation of neutrophil function, and we thus supposed its interaction to occur at PKC level. Since we observed a significant reduction of PKC activity by HHC, we further specified its effect on PKCα, βII phosphorylation. Inhibition of PKC activity and PKCα, βII phosphorylation by HHC only, indicates that the presence of the double bond between C3 and C4 at ring C is necessary for this effect. Structure dependence of the inhibitory effect of polyphenolic antioxidants on signal transduction enzymes, such as PKC, was found also by Varga et al. . Although a specific role for PKCδ in the PMA-dependent intracellular activation process was reported , we did not observe any effect of coumarines tested on phosphorylation of PKCδ.
One of the cytosolic components of the NADPH oxidase, p40phox, which is specifically translocated to intracellular phagosomal and granule membranes, was also indicated as a further determining factor for intracellular ROS production [10, 12]. Moreover, a reduction of p40phox phosphorylation by PKC inhibitors was found by Bouin et al.  and Someya et al. . Our results, however, showed that in PMA stimulated neutrophils reduction of intracellular ROS generation and PKC activity by HHC was not associated with inhibition of phosphorylation of the NADPH oxidase subunit p40phox.
We extended our previous findings about the actions of the coumarine derivatives HHC and HHDC on the activity of human neutrophils by investigating the influence of extra- and intracellular ROS formation and some possible molecular mechanisms affecting the regulation of oxidant production. The presented results suggest that, in pathological processes in which neutrophils are involved, HHDC may act predominantly as a potent inhibitor/scavenger of extracellularly produced ROS. HHC may act both extra- and intracellularly, and, besides its direct interference with ROS, it may interfere also with the PKC signalling pathway. These findings confirmed our previous assumption that the different effects of the coumarine derivatives tested might be due to their diverse molecular structures, which provides them with different physicochemical and free radical scavenging characteristics.
Conflict of Interests
The authors state no conflict of interests.
This study was supported by Grants VEGA 2/0010/13, APVV-0052-10, and APVV-0315-07. The authors thank Professor Magda Kouřilová-Urbanczik for English language correcting of the paper.
- M. E. Riveiro, A. Moglioni, R. Vazquez et al., “Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells,” Bioorganic and Medicinal Chemistry, vol. 16, no. 5, pp. 2665–2675, 2008.
- F. Belluti, G. Fontana, L. D. Bo, N. Carenini, C. Giommarelli, and F. Zunino, “Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: identification of novel proapoptotic agents,” Bioorganic and Medicinal Chemistry, vol. 18, no. 10, pp. 3543–3550, 2010.
- I. Kostova, S. Bhatia, P. Grigorov et al., “Coumarins as antioxidants,” Current Medicinal Chemistry, vol. 18, no. 25, pp. 3929–3951, 2011.
- K. V. Sashidhara, A. Kumar, R. P. Dodda et al., “Coumarin-trioxane hybrids: synthesis and evaluation as a new class of antimalarial scaffolds,” Bioorganic & Medicinal Chemistry Letters, vol. 22, no. 12, pp. 3926–3930, 2012.
- R. Ramasamy, M. Maqbool, A. L. Mohamed, and R. M. Noah, “Elevated neutrophil respiratory burst activity in essential hypertensive patients,” Cellular Immunology, vol. 263, no. 2, pp. 230–234, 2010.
- M. Ciz, P. Denev, M. Kratchanova, O. Vasicek, G. Ambrozova, and A. Lojek, “Flavonoids inhibit the respiratory burst of neutrophils in mammals,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 181295, 6 pages, 2012.
- A. I. Khlebnikov, I. A. Schepetkin, N. G. Domina, L. N. Kirpotina, and M. T. Quinn, “Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems,” Bioorganic and Medicinal Chemistry, vol. 15, no. 4, pp. 1749–1770, 2007.
- K. A. Gauss, L. K. Nelson-Overton, D. W. Siemsen, Y. Gao, F. R. DeLeo, and M. T. Quinn, “Role of NF-κB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-α,” Journal of Leukocyte Biology, vol. 82, no. 3, pp. 729–741, 2007.
- H. Raad, M. H. Paclet, T. Boussetta et al., “Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox,” FASEB Journal, vol. 23, no. 4, pp. 1011–1022, 2009.
- J. Bylund, K. L. Brown, C. Movitz, C. Dahlgren, and A. Karlsson, “Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for?” Free Radical Biology and Medicine, vol. 49, no. 12, pp. 1834–1845, 2010.
- A. Karlsson and C. Dahlgren, “Assembly and activation of the neutrophil NADPH oxidase in granule membranes,” Antioxidants and Redox Signaling, vol. 4, no. 1, pp. 49–60, 2002.
- J. D. Matute, A. A. Arias, N. A. M. Wright et al., “A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40phox and selective defects in neutrophil NADPH oxidase activity,” Blood, vol. 114, no. 15, pp. 3309–3315, 2009.
- H. Björnsdottir, D. Granfeldt, A. Welin, J. Bylund, and A. Karlsson, “Inhibition of phospholipase A2 abrogates intracellular processing of NADPH-oxidase derived reactive oxygen species in human neutrophils,” Experimental Cell Research, vol. 319, no. 5, pp. 761–774, 2013.
- G. Nimeri, M. Majeed, H. Elwing, L. Öhman, J. Wetterö, and T. Bengtsson, “Oxygen radical production in neutrophils interacting with platelets and surface-immobilized plasma proteins: role of tyrosine phosphorylation,” Journal of Biomedical Materials Research A, vol. 67, no. 2, pp. 439–447, 2003.
- J. El-Benna, P. M. C. Dang, M. A. Gougerot-Pocidalo, J. C. Marie, and F. Braut-Boucher, “p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases,” Experimental and Molecular Medicine, vol. 41, no. 4, pp. 217–225, 2009.
- N. J. Hong, G. B. Silva, and J. L. Garvin, “PKC-α mediates flow-stimulated superoxide production in thick ascending limbs,” American Journal of Physiology—Renal Physiology, vol. 298, no. 4, pp. F885–F891, 2010.
- H. M. Korchak, L. B. Dorsey, H. Li, D. Mackie, and L. E. Kilpatrick, “Selective roles for α-PKC in positive signaling for O2-generation and calcium mobilization but not elastase release in differentiated HL60 cells,” Biochimica et Biophysica Acta, vol. 1773, no. 3, pp. 440–449, 2007.
- J. B. Nixon and L. C. McPhail, “Protein kinase C (PKC) isoforms translocate to triton-insoluble fractions in stimulated human neutrophils: correlation of conventional PKC with activation of NADPH oxidase,” Journal of Immunology, vol. 163, no. 8, pp. 4574–4582, 1999.
- A. Bertram and K. Ley, “Protein kinase C isoforms in neutrophil adhesion and activation,” Archivum Immunologiae et Therapiae Experimentalis, vol. 59, no. 2, pp. 79–87, 2011.
- J. Vrba, Z. Dvořák, J. Ulrichová, and M. Modrianský, “Conventional protein kinase C isoenzymes undergo dephosphorylation in neutrophil-like HL-60 cells treated by chelerythrine or sanguinarine,” Cell Biology and Toxicology, vol. 24, no. 1, pp. 39–53, 2008.
- L. E. Kilpatrick, S. Sun, H. Li, T. C. Vary, and H. M. Korchak, “Regulation of TNF-induced oxygen radical production in human neutrophils: role of δ-PKC,” Journal of Leukocyte Biology, vol. 87, no. 1, pp. 153–164, 2010.
- G. E. Brown, M. Q. Stewart, H. Liu, V. L. Ha, and M. B. Yaffe, “A novel assay system implicates PtdIns(3,4)P2, PtdIns(3)P, and PKCδ in intracellular production of reactive oxygen species by the NADPH oxidase,” Molecular Cell, vol. 11, no. 1, pp. 35–47, 2003.
- K. Drábiková, T. Perečko, R. Nosáľ et al., “Different effect of two synthetic coumarin-stilbene hybrid compounds on phagocyte activity,” Neuroendocrinology Letters, vol. 31, pp. 73–78, 2010.
- V. Jančinová, T. Perečko, R. Nosáľ, D. Košťálová, K. Bauerová, and K. Drábiková, “Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition,” European Journal of Pharmacology, vol. 612, pp. 161–166, 2009.
- R. Nosáľ, T. Perečko, V. Jančinová, K. Drábiková, J. Harmatha, and K. Sviteková, “Naturally appearing N-feruloylserotonin isomers suppress oxidative burst of human neutrophils at the protein kinase C level,” Pharmacological Reports, vol. 63, pp. 790–798, 2011.
- K. Drábiková, T. Perečko, R. Nosál et al., “Glucomannan reduces neutrophil free radical production in vitro and in rats with adjuvant arthritis,” Pharmacological Research, vol. 59, pp. 399–403, 2009.
- V. Jančinová, T. Perečko, R. Nosáľ, J. Harmatha, J. Šmidrkal, and K. Drábiková, “The natural stilbenoid pinosylvin and activated neutrophils: effects on oxidative burst, protein kinase C, apoptosis and efficiency in adjuvant arthritis,” Acta Pharmacologica Sinica, vol. 33, pp. 1285–1292, 2012.
- K. Drábiková, V. Jančinová, R. Nosáľ, J. Pečivová, T. Mačičková, and P. Turčáni, “Inibitory effect of stobadine on FMLP-induced chemiluminescence in human whole blood and isolated polymorphonuclear leukocytes,” Luminescence, vol. 22, pp. 67–71, 2007.
- Z. Varga, E. Kosaras, E. Komodi et al., “Effects of tocopherols and 2,2′-carboxyethyl hydroxychromans on phorbol-ester-stimulated neutrophils,” Journal of Nutritional Biochemistry, vol. 19, no. 5, pp. 320–327, 2008.
- D. E. Stevenson and R. D. Hurst, “Polyphenolic phytochemicals—just antioxidants or much more?” Cellular and Molecular Life Sciences, vol. 64, no. 22, pp. 2900–2916, 2007.
- K. B. Pandey and S. I. Rizvi, “Plant polyphenols as dietary antioxidants in human health and disease,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270–278, 2009.
- M. E. Obrenovich, N. G. Nair, A. Beyaz, G. Aliev, and V. P. Reddy, “The role of polyphenolic antioxidants in health, disease, and aging,” Rejuvenation Research, vol. 13, no. 6, pp. 631–643, 2010.
- M. Štefek, “Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract,” Interdisciplinary Toxicology, vol. 4, no. 2, pp. 69–77, 2011.
- T. Perečko, V. Jančinová, K. Drábiková, R. Nosál', and J. Harmatha, “Structure-efficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene,” Neuroendocrinology Letters, vol. 29, no. 5, pp. 802–805, 2008.
- T. Perečko, K. Drábiková, R. Nosáľ, J. Harmatha, and V. Jančinová, “Pharmacological modulation of activated neutrophils by natural polyphenols,” in Recent Research Developments in Pharmacology, S. G. Pandalai, Ed., vol. 2, pp. 27–67, Research Signpost, Trivandrum, India, 2011.
- C. Dahlgren and A. Karlsson, “Respiratory burst in human neutrophils,” Journal of Immunological Methods, vol. 232, no. 1-2, pp. 3–14, 1999.
- L. M. Kabeya, A. A. de Marchi, A. Kanashiro et al., “Inhibition of horseradish peroxidase catalytic activity by new 3-phenylcoumarin derivatives: synthesis and structure-activity relationships,” Bioorganic and Medicinal Chemistry, vol. 15, no. 3, pp. 1516–1524, 2007.
- M. F. Andrade, L. M. Kabeya, A. E. Azzolini et al., “3-Phenylcoumarin derivatives selectively modulate different steps of reactive oxygen species production by immune complex-stimulated human neutrophils,” International Immunopharmacology, vol. 1, pp. 387–394, 2013.
- J. Pečivová, T. Mačičková, J. Harmatha, K. Sviteková, and R. Nosáľ, “In vitro effect of pinosylvin and pterostilbene on human neutrophils,” Interdisciplinary Toxicology, vol. 3, article A73, 2010.
- Z. Varga, I. Seres, E. Nagy et al., “Structure prerequisite for antioxidant activity of silybin in different biochemical systems in vitro,” Phytomedicine, vol. 13, no. 1-2, pp. 85–93, 2006.
- H. C. Lin, S. H. Tsai, C. S. Chen et al., “Structure-activity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities,” Biochemical Pharmacology, vol. 75, no. 6, pp. 1416–1425, 2008.
- K. F. Devienne, A. F. Cálgaro-Helena, D. J. Dorta et al., “Antioxidant activity of isocoumarins isolated from Paepalanthus bromelioides on mitochondria,” Phytochemistry, vol. 68, no. 7, pp. 1075–1080, 2007.
- C. G. Fraga, M. Galleano, S. V. Verstraeten, and P. I. Oteiza, “Basic biochemical mechanisms behind the health benefits of polyphenols,” Molecular Aspects of Medicine, vol. 31, no. 6, pp. 435–445, 2010.
- R. Nosáľ, T. Perečko, V. Jančinová, K. Drábiková, J. Harmatha, and K. Sviteková, “Suppression of oxidative burst in human neutrophils with the naturally occurring serotonin derivative isomer from Leuzea carthamoides,” Neuroendocrinology Letters, vol. 31, pp. 69–72, 2010.
- V. Jančinová, T. Perečko, K. Drábiková, R. Nosáľ, and K. Sviteková, “Piceatannol, a natural analogue of resveratrol, inhibits oxidative burst of human neutrophils,” Interdisciplinary Toxicology, vol. 4, pp. A35–A36, 2011.
- A. P. Bouin, N. Grandvaux, P. V. Vignais, and A. Fuchs, “p40(phox) is phosphorylated on threonine 154 and serine 315 during activation of the phagocyte NADPH oxidase: implication of a protein kinase C-type kinase in the phosphorylation process,” Journal of Biological Chemistry, vol. 273, no. 46, pp. 30097–30103, 1998.
- A. Someya, H. Nunoi, T. Hasebe, and I. Nagaoka, “Phosphorylation of p40-phox during activation of neutrophil NADPH oxidase,” Journal of Leukocyte Biology, vol. 66, no. 5, pp. 851–857, 1999.